arrow
S

Stephan Mathas

Charité Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine
H指数:37
被引数:5,791

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase 2 GHSG NIVAHL Trial

Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase 2 GHSG NIVAHL Trial

Blood
IF23.1
2026-04-070
PRE
At the crossroads of infection and malignancy: the challenge of tuberculosis in migrating populations – Case Report and Epidemiologic Analysis

感染与恶性疾病交汇处的挑战:结核病在迁移人群中的病例报告与流行病学分析

2025-12-230
OAAI
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms

人类和鼠类ALK阳性B细胞肿瘤的DNA甲基化比较分析

2025-07-260
OA
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial

高级别经典霍奇金淋巴瘤患者在接受BrECADD与eBEACOPP治疗后的生育能力比较:一项多中心、随机、平行、开放标签、III期HD21试验的二次分析

2025-07-100
OAAI
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression

JUN介导衰老相关的分泌表型和免疫细胞募集以预防前列腺癌进展

2024-05-292
OAAI
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trial
2024-03-015
OA
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial
2024-03-016
PRE
Transcriptional reprogramming by mutated IRF4 in lymphoma

淋巴瘤中突变IRF4的转录重编程

2023-11-071
OAAI
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
2023-06-1513
OAAI
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
2023-01-1313
PRE
PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
2022-08-319
OAAI
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas
2022-04-284
OAAI
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma
2022-02-191
OAAI
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
2021-09-2228
OAAI
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
LEUKEMIA
IF13.4
2021-08-1821
OAAI
The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
LEUKEMIA
IF13.4
2018-03-2866
OAAI